Full Text View
Tabular View
No Study Results Posted
Related Studies
A Randomized Trial of Carvedilol in Chronic Chagas Cardiomyopathy
This study has been completed.
Study NCT01557140   Information provided by Federal University of Minas Gerais

First Received on February 21, 2012.   Last Updated on March 16, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chagas Cardiomyopathy
Heart Failure
Dilated Cardiomyopathy
Additional conditions recognized in this trial
Cardiomyopathies
Cardiomyopathy, Dilated
More general conditions related to this trial
Cardiomegaly
Cardiovascular Diseases
Chagas Disease
Euglenozoa Infections
Heart Diseases
Parasitic Diseases
Protozoan Infections
Trypanosomiasis
Interventions listed in this trial
RASi plus carvedilol
Additional drug interventions recognized in this trial
Carvedilol
Natriuretic Peptide, Brain
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic alpha-1 Receptor Antagonists
Adrenergic alpha-Antagonists
Adrenergic Antagonists
Adrenergic beta-Antagonists
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Federal University of Minas Gerais


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services